A plethora of defense giants just reported their Q4 2025 earnings. The cycle saw some standout performances, as well as others that left investors wanting more.
2026 is well underway and off to a bullish start. The S&P 500 and other major indices are ending January at record highs, and the Russell 2000 INDEXRUSSELL: RUT, which tracks small-cap stocks, is leading the charge.
Winter Storm Fern has slammed into the United States, encasing 34 states in ice and forcing millions of Americans to crank up their thermostats. While meteorologists track the plunging temperatures and an incoming bomb cyclone that could bring blizzard conditions and even more snow to the United States, Wall Street is tracking a different metric: the spark spread.
Winter Storm Fern rattles the United States, lifting heating demand and natural gas prices as UNG stands out while airlines and consumers face headwinds.
For the past five years, investors who have stayed entirely invested in the highest-growth stocks in the market (and some of the largest-capitalization stocks in their sectors, for that matter) have outperformed.
With favorable regulations encouraging a boom in domestic nuclear power, several prominent uranium miners have experienced skyrocketing shares in the last year. Canadian outfit Cameco Corp. NYSE: CCJ, among the largest producers of uranium in the world, has risen by 161% in the last year, for instance.
What can a focused approach to equity portfolio construction offer for advisors and investors? Recently, Dr. Ankur Crawford, portfolio manager at Alger, joined Todd Rosenbluth, VettaFi's head of research, to discuss this very topic.
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk.
Artificial intelligence stocks have been some of the best investments over the past year.
Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.
STLA's Dodge Charger, Ford Maverick Lobo, and Hyundai Palisade claim 2026 NACTOY honors.
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak.